Trials / Sponsors / Noema Pharma AG
Noema Pharma AG
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome Tourette Syndrome | Phase 2 | 2024-09-10 |
| Completed | A Study of NOE-115 in Women With Vasomotor Symptoms Due to Menopause Menopause Syndrome, Menopause, Hot Flashes | Phase 2 | 2024-04-22 |
| Completed | A 10-week Efficacy Study of NOE-105 in Childhood Onset Fluency Disorder (Orpheus) Childhood-Onset Fluency Disorder | Phase 2 | 2022-07-25 |
| Completed | Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSC Tuberous Sclerosis Complex | Phase 2 | 2022-03-03 |
| Active Not Recruiting | An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients With Trigeminal Neuralgia. Trigeminal Neuralgia | Phase 2 / Phase 3 | 2022-01-11 |
| Completed | A Study to Validate a Pain Diary for Patient With Trigeminal Neuralgia Trigeminal Neuralgia | — | 2021-11-20 |